In obese CRC patients, elevated oxLDL levels and heightened NF-κB immunoreactivity in tumor tissues were observed, with advanced-stage patients exhibiting even higher NF-κB activation (p < 0.05 for all comparisons). This evidence concerns the gene NFKB1 and colorectal carcinoma.